Birchview Capital’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Birchview Capital’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-14,000	Closed	-$249K	–	60
2018 Q3	$249K	Buy	14,000 +4,000	+40%	+$68.7K	0.16%	48
2018 Q2	$138K	Buy	+10,000	New	+$119K	0.09%	50

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Birchview Capital's ECYT Position: Q4 2018 in Review

Birchview Capital sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 14,000 shares — an estimated $249K sold.

Birchview Capital first reported a position in ECYT in Q2 2018 and held it in 2 quarters. The position peaked at $249K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Birchview Capital reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Birchview Capital sold 14,000 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $249K.
Birchview Capital first reported a position in Endocyte, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
Birchview Capital's Endocyte, Inc. Common Stock position peaked at $249K in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Birchview Capital's 13F filing for Q4 2018, filed 6 Feb 2019.